
Tick Bite? Here's What to Know About Lyme Disease and Your Next Steps
You just finished a satisfying summer hike or wrapped up a weekend of yard work when you spot a tick clinging to your clothes. The fresh-air high fades quickly as you remember the risks -- ticks are known carriers of Lyme disease, a growing concern across the US.
Lyme disease cases have more than doubled in recent years, according to the CDC, with annual reports jumping from around 42,000 to nearly 90,000. While part of that increase is due to improved detection and reporting methods, the risk is still very real. Whether you're spending time on the trails or just working in your backyard, it's worth knowing how to prevent tick bites, recognize early symptoms and get treatment if needed. A little awareness can go a long way in keeping you and your loved ones safe this summer.
What is Lyme disease?
You can get Lyme disease when a tick bites you, spreading a specific type of bacteria.
Dr. Bobbi Pritt, a pathologist who specializes in the laboratory diagnosis of vector-borne and parasitic diseases, explains the disease more in-depth: "Lyme disease is a bacterial infection spread to humans through the bite of infected blacklegged (deer) ticks. In the United States, it is caused primarily by Borrelia burgdorferi, and to a lesser extent, Borrelia mayonii. Lyme disease is the number-one cause of tick-transmitted disease in the United States."
However, the tick has to carry the bacteria to give you Lyme disease. Not all ticks carry the bacteria. According to the Global Lyme Alliance, anywhere from under 1% to over 50% of black-legged ticks may carry Borrelia burgdorferi, depending on location. However, they may have other pathogens.
Dr. Donald Harker, wilderness medicine fellow at the University of Nevada, Reno, says, "Borrelia burgdorferi is a bacterial spirochete that lives in the midgut of infected ticks, typically requiring extended attachment of a tick to host for transmission to occur."
Lyme disease symptoms
"There are three stages of disease including early localized, early disseminated and late disseminated Lyme disease," says Harker.
Stage 1 Lyme disease symptoms
The Mayo Clinic lists symptoms of the early stage occurring three to 30 days after an infected tick has bitten you.
Pritt says the early localized state can include "fever, fatigue, headache, muscle and joint pains and a characteristic 'bull's-eye' rash (known as erythema migrans) at the tick bite site. The rash is seen in about 70% of infected people, but it may go unnoticed, especially if it is on a part of the body that isn't easily seen, such as the scalp or back. The rash enlarges over time and sometimes clears to create the classic target or 'bull's-eye' appearance."
Dr. Omar Al-Heeti, an assistant professor of medicine at Southern Illinois University who practices internal medicine with a specialty in infectious diseases, and one of CNET's medical reviewers, adds, "More common than not, there is not central clearing or 'target' appearance. The rash should be larger than 5 cm."
Willowpix/Getty Images
Stage 2 Lyme disease symptoms
Stage 2 of Lyme disease tends to happen three to 10 weeks after the tick bite.
During stage 2, symptoms can already become serious or deadly. According to Harker, "During transition to early disseminated disease, multiple erythema migrans rashes may develop more distant from the original bite location, along with flu-like symptoms, cranial nerve palsy, meningitis or cardiac conduction abnormalities. While Lyme carditis [occurs when Lyme disease bacteria enter the heart's tissue] is rare, it is a significant cause of Lyme disease-related mortality and has been documented to result in complete heart block in as little as four days after infection."
The Mayo Clinic lists additional symptoms like neck pain and stiffness, painful swelling around the eye or eyelid, eye nerve pain or vision loss, muscle weakness that can happen on one or both sides of the face and body pain.
Stage 3 Lyme disease symptoms
Symptoms from earlier stages can persist into stage 3. But a host of new serious symptoms might arise, characterized most commonly by arthritis in large joints.
"The last stage, late disseminated Lyme disease, presents months to years after the initial tick bite," Harker says. "Characteristic symptoms of late disseminated Lyme disease include Lyme arthritis with pain in one or more major joints and nervous system involvement including sleep disturbance, memory loss, mood swings, migraine, encephalopathy [a change in how your brain functions], vertiginous dizziness and peripheral paresthesia [the sensation of tingling, prickling or numbness]."
Post-Treatment Lyme disease syndrome symptoms
"Some people experience fatigue, joint pain and brain fog lasting six months or more – this is called Post-Treatment Lyme Disease Syndrome (PTLDS), and it can be very debilitating for some people," Pritt states.
No one quite knows why symptoms may persist after treatment. According to Harker, "The etiology of PTLDS is unclear, though several mechanisms have been proposed, including microbial persistence, though no evidence has shown continued infection. Other proposed mechanisms include immune dysregulation, autoimmunity, residual inflammation or gut microbiome alterations, though further research is required at this point."Lyme disease risk factors
Since ticks transmit Lyme disease, it primarily affects people who spend the most time outside in certain regions. Pritt identifies the following risk factors: "Living or spending time in wooded or grassy areas, especially in the Northeast, upper Midwest and Pacific Northwest US, and not using protection against tick bites when outdoors."
Harker mentions other risk factors: "Seasonally, the risk of infection is highest during late spring, summer and early fall when nymphal ticks are most active, though climate changes have enabled tick expansion to regions that have historically not experienced as much tick-borne illness. House pets are also able to bring ticks into the home, with the largest risk associated with cats. Lastly, we do see an increased incidence of infection in certain age groups, including children less than 15 and individuals aged 50-70 years old."
How is Lyme disease diagnosed?
Pritt outlines the whole diagnostic process: "Lyme disease is usually diagnosed through a review of the patient's symptoms in conjunction with a history of tick exposure, and blood tests to detect the patient's immune response to the bacteria (called serologic testing). When present, the bull's-eye rash is considered diagnostic of Lyme disease in endemic areas and should prompt immediate treatment. However, not all cases of Lyme disease are straightforward, and laboratory testing can play a crucial role in making the diagnosis, particularly in the later stages of disease."
How is Lyme disease treated? Can it be cured?
Pritt states that doctors treat with antibiotic courses like doxycycline. Harker adds that treatment may vary based on how someone's symptoms manifest, which organs are infected and what stage of infection the person is experiencing. Oral antibiotics tend to go to those who exhibit rashes. People with more serious symptoms like neurologic issues or heart problems might get IV antibiotics. People with a tick bite and potential exposure may get prophylactic postexposure antibiotics if it is noted that the tick is the deer tick, the bite occurred in a highly endemic area and the tick was attached for over 36 hours.
Treatments can get even more involved for the worst complications. According to Harker, "[For] cardiac manifestations, IV antibiotics [may be used], with a potential need for a pacemaker if [there is the] presence of a symptomatic heart block."
Pritt adds, "Lingering after-treatment symptoms can be very troublesome and challenging to treat. Rest, physical therapy, stress management and support from healthcare providers can help manage symptoms." She adds that lingering symptoms might result from an overactive immune response or residual tissue damage, rather than ongoing infection.
Al-Heeti adds, "Long-term antibiotics are not recommended for PTLDS or chronic Lyme as sometimes prescribed."
rbkomar/Getty Images
What to do if a tick bites you
Follow these steps if you notice that a tick has bitten you:
Remove the tick immediately. "Mechanical removal is generally recommended by experts, and the CDC has endorsed removal with forceps [or tweezers]. During removal, forceps should be placed as close to the skin as possible and force should be applied steadily perpendicular to the skin surface, without twisting and with care used not to crush the tick," says Harker.
"Mechanical removal is generally recommended by experts, and the CDC has endorsed removal with forceps [or tweezers]. During removal, forceps should be placed as close to the skin as possible and force should be applied steadily perpendicular to the skin surface, without twisting and with care used not to crush the tick," says Harker. Clean the area. The CDC says rubbing alcohol or soap and water is OK. Also, make sure to clean both your hands and the bite area.
The CDC says rubbing alcohol or soap and water is OK. Also, make sure to clean both your hands and the bite area. Safely save the tick. "Save the tick, if possible, for identification," recommends Pritt. The CDC advises that you dispose of the tick by "putting it in alcohol, placing it in a sealed bag or container, wrapping it tightly in tape or flushing it down the toilet." Do not crush it with your fingers.
"Save the tick, if possible, for identification," recommends Pritt. The CDC advises that you dispose of the tick by "putting it in alcohol, placing it in a sealed bag or container, wrapping it tightly in tape or flushing it down the toilet." Do not crush it with your fingers. Watch for symptoms and keep in touch with your doctor. Keep an eye out for telltale symptoms like the bull's-eye rash. If exposure is likely and you live in the Northeast, you might consider getting preventative antibiotics from a doctor.
How to prevent Lyme disease
There are currently no Lyme disease vaccines on the market. "A new vaccine is in development and could become available in the next few years, pending approval," says Pritt. There are some in human trials at the moment, says Harker.
Since Lyme disease can range from asymptomatic to deadly, it's best to avoid ticks in the first place using a few easy preventative measures.
Use tick repellent
Harker recommends tick repellants like DEET or picaridin. He also suggests finding tick-resistant clothing treated with permethrin.
Dress appropriately outdoors
Pritt recommends wearing long sleeves and pants when outdoors. Harker reminds us that you can tuck clothing into the waist of pants and socks to minimize gaps that pests can get into.
"Light-colored clothing may also aid in the early identification of ticks attached to clothing," says Harker.
Perform tick checks
"As transmission of the bacteria that causes Lyme disease typically requires a tick to be attached for 15 to 48 hours, frequent skin checks for possible tick exposure should be performed when in outdoor areas with risk of contact," Harker says.
You should also perform frequent tick checks while outside and after. "Showering after being in tick-prone areas can help to identify ticks on your body," says Pritt. "Be sure to check all of the members of your group, including your pets."
When to contact a doctor
Pritt takes a pragmatic approach: "If you develop a rash, fever or flu-like symptoms within 30 days, or if the tick was attached for more than 24 hours, then you should contact your doctor to see if you should be tested for tick-borne diseases."
Harker also says you should contact your doctor if there is any concern, as he states that "prophylactic antibiotics may be indicated and are best administered within the first 72 hours after the tick bite."
The bottom line
Lyme disease is caused by bacteria that live in the deer tick. People contract the disease after the tick has bitten them and been on their bodies for most of the day or longer. Symptoms go in three stages and may start with the signature bull's-eye rash. Later stages can mean arthritis, heart problems, stiffness and pain in the body, eye pain or vision loss and muscle weakness.
It's best to prevent tick bites by covering as much skin as possible outdoors, with regular tick checks and by using tick repellant.
Lyme disease FAQs
Can Lyme disease go away on its own?
According to Cedars Sinai, if untreated, the Lyme infection may go away on its own. However, if untreated, you may have to deal with complications down the line. Watch out for symptoms and contact your doctor if there are any concerns.
Can you live long with Lyme disease?
Yes, you can live a long life even if you contract Lyme disease – especially if it is diagnosed and treated early. Brown University Health reports that it is very unlikely for someone to die from Lyme disease.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
21 minutes ago
- CBS News
Maryland LGBTQ+ advocates vow to bolster resources with 988 lifeline set to end
Maryland LGBTQ+ organizations are stepping up for youth as a national resource is set to end in less than a month. The Trump administration announced that the 988 Suicide and Crisis Lifeline will end its lifeline dedicated to LGBTQ+ youth by July 17. The lifeline has also been known as the Press 3 Option. Advocates are making sure the youth who rely on this service continue getting the help they need. Preparing for the lifeline's end The end of the lifeline came as no surprise to Cleo Manago, CEO of The Pride Center of Maryland. So, to prepare, he and his team have been working to create a suicide warm line. "During traditional work hours, there will be live people to speak to about any suicidal concerns or ideations," Manago said. "For the rest of the time, there will be a recording that will alert people where they can call and where they can go [for help]." This is on top of bolstering other suicide prevention and youth programming that the center does. In its announcement, the Substance Abuse and Mental Health Services Administration, or SAMHSA, said the lifeline -- also known as the Press 3 option -- is ending on July 17. The need for the lifeline LGBTQ+ youth are four times more likely to die by suicide, according to The Trevor Project, a national nonprofit that is dedicated to ending LGBTQ+ suicide. In its annual survey looking at mental health in LGBTQ+ youth, The Trevor Project found in Maryland that 40% considered suicide, 57% experienced symptoms of anxiety, and 48% experienced symptoms of depression. When looking at the numbers for transgender and non-binary youth specifically, all categories reported higher numbers. Tanner Mobley, an advocacy manager for The Trevor Project based in Baltimore, said about half of their contacts come from 988. Right now, he and his team are working to get Congress to reverse the decision to keep the lifeline operating. "I'm not gonna sugarcoat it, we're gonna lose lives," Mobley said. "These are kids who have been kicked out of their homes, who have been bullied at school for being LGBTQ+, and have been rejected by their communities. When they're calling in a moment of crisis, they need someone who understands that." Until the lifeline leaves or stays, Mobley and Manago say they're gonna work even harder to ensure LGBTQ+ youth are cared for. "Something is always bound to happen, and there's always a great potential for a lack of support. So, I've been doing what I can to bolster the support systems and diversify our resources to make sure we can survive these kind of attacks." A full listing of services provided by The Pride Center of Maryland can be found here. For services from The Trevor Project, you can find them here.
Yahoo
26 minutes ago
- Yahoo
Gold Coast Health Plan Announces Inaugural Grant Awards to Expand Health Care Access Across Ventura County
Resilience, Innovation, Sustainability & Equity (RISE) Grant Program Launches with nearly $22-Million Investment in Community-Based Care CAMARILLO, Calif., June 25, 2025 /PRNewswire/ -- Gold Coast Health Plan (GCHP) today announced the inaugural recipients of its new Resilience, Innovation, Sustainability & Equity (RISE) Grant Program—a three-year initiative with an initial commitment of $21.9 million dollars and second- and third-year opportunities for applications. The program is aimed at strengthening Ventura County's health care infrastructure and improving access to care for Medi-Cal members. Launched in early 2025, the RISE Grant Program is a three-year initiative designed to address critical gaps in physical and behavioral health care. Through strategic investments, GCHP is empowering organizations that serve GCHP members, such as hospitals, clinics, nonprofit organizations, and third-party administrators, to implement initiatives that improve access, enhance patient experience, and promote health equity. "Our strategic investments and collaboration with provider and community groups have accelerated our ability to connect more members with care," said Dr. Felix Nuñez, GCHP's chief executive officer (CEO). "With the RISE grant program, we want to engage our entire community in this effort to improve health outcomes for all Medi-Cal members." Following a competitive process and thorough review, GCHP's grant management partner, the Institute of Health Improvement (IHI), selected the following 16 organizations and projects for RISE Grant funding, totaling $11.3 million for the first year, with some organizations receiving multi-year funding: Cancer Screenings Health Care Foundation for Ventura County, Inc.: $2,034,970 Ventura County Medical Center Women's Health Breast Imaging Center: Aims to improve equitable access and patient outcomes by increasing capacity and reducing wait times through equipment upgrades and improved service efficiency. Clinicas del Camino Real Inc.: $2 million El Rio Urgent Care Expansion: Aims to expand access to Clinicas Urgent Care and mammography services by renovating the El Rio clinic to add a nine-room urgent care center on site and adding a new mammography mobile unit. Conejo Free Clinic: $165,000 Women's Wellness & Equity Initiative: Bridging Gaps in Preventive Care: Aims to improve access to screenings and wellness services by expanding the clinic into the adjacent suite, adding two exam rooms, and increasing the number of well-woman clinics held each month. Mental Health Community Memorial Health System, dba Community Memorial Healthcare: $2,847,994 Behavioral Health Psychiatry Program: Aims to provide high-quality medical and behavioral health care by integrating psychiatry residents across CMH sites and county facilities. The Boys & Girls Clubs of Greater Oxnard and Port Hueneme: $352,151 Mental Health Services for Youth Club Members: Aims to improve the health and well-being of youth members by integrating mental health services into the Clubs' out-of-school programs. Nate's Place, A Wellness and Recovery Center: $319,500 Expanding Low Barrier Mental Health and Substance Use Services: Aims to improve access to mental health and substance use disorder (SUD) services. Nutrition and Food Access Food Share: $150,000 Fresh for All: Expanding Access to Fresh Produce for Low-Income Communities: Aims to expand access to fresh, nutritious produce by providing 30,000 fresh produce boxes to members directly in high-need communities. California State University, Northridge: $77,437 The University Corporation (TUC) – Every Family Every Market: Aims to increase access to fresh fruits and vegetables through technical assistance targeted to Ventura County farmers to use the new electronic benefits program (i.e., eFM) for the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) and through provision of health and nutrition education efforts. Pediatrics and Family Care Amigo Baby, Inc.: $280,000 Benefits of Comprehensive Pediatric Home Health Services: Aims to expand equitable, in-home pediatric therapy and nursing services, focusing on underserved areas such as Santa Paula, Fillmore, and Oxnard. Shelter Care Resources: $152,500 Shelter Care Resources Wraparound Health Care: Aims to increase health care access and alternative solutions for Medi-Cal eligible homeless youth and families by addressing challenges to enrollment, digital access, and transportation. United Way of Ventura County: $67,136 Building Healthy Smiles (BHS): Aims to expand the capacity of BHS services to facilitate school screenings events. Partners will provide care coordination for students with urgent needs, with a focus on equity and inclusivity, ensuring that underserved students have access to essential dental care. Primary Care Access Ventura County Medical System: $1,554,106 Expanding Health care Access and Colon Cancer Screening in Ventura County: Aims to expand health care access by increasing clinic capacity at Magnolia Family Medical Clinic in Oxnard and enhancing gastrointestinal services at Santa Paula Hospital. Livingston Memorial Visiting Nurse Association: $488,885 The Livingston Bridge Program: Aims to improve access to care through in-home visits, remote monitoring, and support. Public Health and Prevention Ventura County Public Health: $357,106 Ventura County Public Health Mobile Team: Aims to provide health education, sexually transmitted infection screening, and application assistance for health coverage to unhoused individuals. Women's Health Mixteco Indigena Community Organizing Project (MICOP): $169,738 Access to Traditional Maternal Care for Indigenous Migrant Communities: Aims to address gaps in access to traditional practices essential to maternal and infant health. Workforce Development Santa Barbara Foundation: $308,413 Central Coast Community Health Workers / Promotores (CHWP) Collaborative: Aims to improve health care access for by supporting organizations in developing a robust, culturally responsive CHWP workforce. "This grant is a lifeline for Ventura County's underserved families, allowing us to provide vital pediatric home health services with compassion and equity," said Pablo Velez, chief executive officer of Amigo Baby, Inc. "Together, we're creating brighter futures for children who need every opportunity to thrive." With this grant program, GCHP is continuing its investment in health care quality and access in Ventura County. GCHP recently supported local health care providers through a multi-year initiative that provided $50 million in incentives for improvements in health care quality, and about $15 million in grants to recruit or retain 90 health care providers and supply 393 pieces of medical equipment to 42 health centers to support access to care. "Our strong partnerships with providers have significantly improved access to care and health outcomes," said GCHP's Chief Policy and Program Officer Erik Cho. "This new grant program builds on that success by extending support to clinics, nonprofits, and other community organizations that meet our members where they are—helping them overcome barriers to accessing the medical care they need and deserve." The grant award period runs from July 1, 2025 to June 30, 2026, during which IHI and GCHP will work closely with grantees to monitor progress, measure outcomes, and share insights to inform future funding cycles. About Gold Coast Health PlanGold Coast Health Plan proudly serves nearly 245,000 Medi-Cal members in Ventura County through its network of primary care physicians, specialists, behavioral health providers and hospitals. Since its founding in 2011, Gold Coast Health Plan has been committed to providing access to high-quality care and improving its members' health, including 1 in 3 county residents, 1 in 6 seniors, and 1 in 2 children under the age of 5. To learn more, visit: Media Contact:Susana Enriquez-Euyoque805-437-5596SEnriquez@ View original content to download multimedia: SOURCE Gold Coast Health Plan Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CNN
32 minutes ago
- CNN
What to know about thimerosal, a target of RFK Jr.'s new CDC vaccine advisers
Vaccines Disability issues Federal agencies Children's healthFacebookTweetLink Follow In the 1930s, vaccine makers began using a preservative called thimerosal to stave off microbial growth in their products. For the next six decades, it didn't receive much notice; ill effects appeared limited to minor local injection-site reactions, according to the US Food and Drug Administration. That changed in 1999, when US health officials asked pharmaceutical companies to remove thimerosal from vaccines. There was no evidence that it caused harm in the quantities used, but thimerosal contains a form of mercury, and questions had emerged about whether it could cause neurotoxicity when given in childhood vaccinations. Vaccine makers have removed it from all but a few shots, such as multidose vials of flu vaccine. In the meantime, subsequent studies have confirmed no link between thimerosal in vaccines and neurodevelopmental issues, including autism, and autism rates have continued to rise. So public health experts were puzzled when the preservative appeared on the agenda for this week's meeting of outside vaccine advisers to the US Centers for Disease Control and Prevention. 'I actually don't know any pediatric practices that even use that multidose influenza vaccine,' said Dr. Sean O'Leary, a pediatrician at Children's Hospital Colorado and former liaison to the CDC's Advisory Committee on Immunization Practices, or ACIP, for the American Academy of Pediatrics. The group is meeting on Wednesday and Thursday for the first time since US Health and Human Services Secretary Robert F. Kennedy Jr. dismissed the committee's previous 17 members, claiming they had conflicts of interest, and days later installed eight new advisers. Public health experts and lawmakers have called into question the credentials and backgrounds of some of the new panelists, and just before the meeting began, one member withdrew during the financial holdings review, an HHS spokesman said, bringing the panel down to seven. A presentation 'regarding thimerosal in vaccines' is scheduled for Thursday morning, followed by 'proposed recommendations' specifically about thimerosal in flu vaccines, according to an agenda posted Monday. The meeting is scheduled to conclude with a vote on the latter, a move that could lead to official CDC policy if adopted by agency leadership – or, without a confirmed director in place, by Kennedy. The last-minute addition of thimerosal to the agenda was a red flag for vaccine experts, who consider the science settled and fear that Kennedy – who led an anti-vaccine group called Children's Health Defense – is seeking to sow doubt about vaccine safety. Another former Children's Health Defense leader, Lyn Redwood, is slated to make a presentation on the topic at the meeting. Here's how thimerosal became such a hot-button issue. In 1997, Rep. Frank Pallone, a New Jersey Democrat concerned about mercury pollution in his community's lakes and rivers, attached an amendment to a US Food and Drug Administration reauthorization bill that would require the agency to catalogue intentionally introduced mercury compounds in drugs and food. That led to a possibly startling discovery: 'As people looked in vaccines, there was the potential that, by six months of age, infants could have received more thimerosal than was listed in several sources of what was considered safe levels of mercury,' said Dr. Walter Orenstein, who was director of the National Immunization Program at the CDC at the time. But those limits were set for methylmercury, the kind found in some fish, which is known to be toxic. Thimerosal contains ethylmercury, a different compound that's 'intrinsically less stable, and more readily metabolized, than methylmercury,' said Dr. Matthew Rand, an associate professor in the Department of Environmental Medicine at the University of Rochester who studies mercury toxicity. That means it's cleared from the body more quickly than methylmercury, according to the CDC, 'and is therefore less likely to cause any harm.' The FDA notes that there were no existing guidelines for ethylmercury. Still, the finding led to a number of emergency meetings among federal health officials and outside groups to determine what should be done, Orenstein recalled. 'While there was no evidence of harm from thimerosal, the general feeling was, 'let's get rid of it, because we don't need it,' ' he said. Moving to single-dose containers alleviated the need for a preservative, although it came at a higher expense for manufacturers. In 1999, the FDA sent a letter to manufacturers of US vaccines requesting their plans to remove thimerosal, and by 2001, the compound had been removed from or reduced in all vaccines routinely recommended for children under 6 in the US, according to the CDC. The message from public health agencies, Orenstein said, was 'we're going to make safe vaccines even safer.' But the die was cast. Vaccines had already been tied to autism in 1998 by British doctor Andrew Wakefield, who published a since-retracted paper that claimed the measles-mumps-rubella vaccine was linked to autism, although not because of thimerosal – the MMR vaccine never contained the preservative. Still, parents of children with autism were seeking answers. One of those parents was Redwood, who said that in 1999, she tallied up her son's mercury exposure and found 'at two months of age, he had received 125 times his allowable exposure to mercury based on EPA's guidelines in his weight.' 'That was a real answer for me,' Redwood said in a video posted by Children's Health Defense this month, 'because my son at this time was almost 5 years old, and he had regressed developmentally after his first year of life and was diagnosed with autism.' Redwood, a nurse practioner, decided to become an advocate, speaking at events and publishing papers about thimerosal and autism. The uproar over a potential link between thimerosal and autism came as a surprise to Orenstein and colleagues. 'Mercury itself had never been implicated as a major cause of autism,' Orenstein said. 'But this was a major, major concern.' It led to a number of studies of the issue, including a 2004 assessment by the Institute of Medicine (now known as the National Academy of Medicine) that concluded 'the body of epidemiological evidence favors rejection of a causal relationship between thimerosal-containing vaccines and autism.' It made the same conclusion for MMR vaccines and autism. A 2010 study by the CDC also found no link. And 'even after thimerosal was removed from almost all childhood vaccines, autism rates continued to increase,' the agency noted, 'which is the opposite of what would be expected if thimerosal caused autism.' Still, those who continued to push the disproven autism connection included Kennedy, who published a book in 2014 called 'Thimerosal: Let the Science Speak.' Its subtitle calls for the 'immediate removal of mercury – a known neurotoxin – from vaccines.' It rejects the findings of the 2004 Institute of Medicine report and warns that millions of children in the US and around the world 'appear to be at risk of injury from the thimerosal in vaccines.' Thimerosal is still present in 'a small percentage of flu vaccines, confined to multidose vials,' according to a post from the Vaccine Integrity Project, a group focused on countering vaccine misinformation that was started at the University of Minnesota's Center for Infectious Disease Research and Policy, or CIDRAP. The group suspects that thimerosal is included on ACIP's agenda this week – with a presentation by Redwood and a vote by the committee – 'to put greater focus on and generate more public discussion about vaccine risk.' HHS didn't return a request for comment about Redwood's involvement in this week's meeting, and Redwood declined to comment. Her presentation slides, however, were posted ahead of the meeting and continued to claim thimerosal presents safety risks. One slide initially included in the presentation cited a study in animals that appeared not to exist; its apparent lead author told CNN he'd published a study with a similar title, but in a different journal, in different animals, and with dramatically different findings — ones that didn't appear to show a link between autism and thimerosal. The slide presentation was subsequently updated to remove that slide. CDC staff also posted its own review of the data, citing nearly two dozen studies showing 'the evidence does not support an association between thimerosal-containing vaccines and autism spectrum disorder or other neurodevelopmental disorders.' During her Senate Health, Education, Labor and Pensions committee confirmation hearing on Wednesday, Dr. Susan Monarez, President Donald Trump's pick to lead the CDC, said, 'I have not seen a causal link between vaccines and autism.' The decision to remove thimerosal from most vaccines, despite no evidence of harm, had other consequences. At the same time the FDA made its request to vaccine makers, US health authorities advised that babies born to mothers known to be negative for hepatitis B not receive a shot for that virus at birth, but at two months to 6 months of age, as thimerosal was phased out. But about 10% of hospitals 'suspended use of the hepatitis B vaccine for all newborns, regardless of their level of risk,' wrote Dr. Paul Offit, a vaccine scientist at the Children's Hospital of Philadelphia and a member of the FDA's outside advisory committee on vaccines, in a 2007 perspective piece in the New England Journal of Medicine. 'One three-month-old child born to a Michigan mother infected with hepatitis B virus died of overwhelming infection.' Orenstein looks back on the decision to remove thimerosal as a hard one. 'The fear would be keeping it in there, doing a study over two or three years and then it showed harm, and lo and behold, for three years, we used this vaccine and this component was harmful,' he said. 'Since we didn't know what the results would be of any of the studies at the time, we thought it better to just get it out of there. 'The autism issue,' he added, 'didn't play any role in the initial decision.' CNN's Brenda Goodman contributed to this report.